Dopamine rushes, withdrawals, and detoxes are trending among wellness gurus online. But experts say the science behind the ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...

The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

The global Parkinson’s disease (PD) market is expected to grow to $7.9 billion by 2033 from $3.4 billion in 2023, according ...

Sep. 24, 2024 — Parkinson's disease ... and neurological disorders attributed to dysfunctions in specific dopamine ... Alzheimer's Drug May Slow Down Cognitive Decline in Dementia With Lewy ...